Search Orphan Drug Designations and Approvals
-
| Generic Name: | leukocyte interleukin |
|---|---|
| Date Designated: | 05/04/2007 |
| Orphan Designation: | Neoadjuvant therapy in patients with squamous cell carcinoma of the head and neck |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
CEL-SCI Corporation 8229 Boone Blvd. Suite 802 Vienna, Virginia 22182 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







